These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21894101

  • 1. Neuroleptic Malignant syndrome (NMS): a rare presentation induced by an antiemetic - case report.
    Kashyap GL, Patel AG.
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S43-5. PubMed ID: 21894101
    [Abstract] [Full Text] [Related]

  • 2. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J, Jakob J, Bender HJ, Hewer W.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A, Borkar HA, Chandak S.
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 5. [Neuroleptic malignant syndrome--a case report].
    Lanczik M, Fritze J.
    Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
    [Abstract] [Full Text] [Related]

  • 6. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 May; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 7. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M, Ancill R.
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome associated with clozapine use.
    Anderson ES, Powers PS.
    J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
    [Abstract] [Full Text] [Related]

  • 9. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T.
    Seishin Shinkeigaku Zasshi; 1998 Mar; 100(6):387-97. PubMed ID: 9745353
    [Abstract] [Full Text] [Related]

  • 10. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W, Elias M, Lev A, Saliba WR.
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [Abstract] [Full Text] [Related]

  • 11. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J, García García J, Alda Diez JA, Tous Andreu N.
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract] [Full Text] [Related]

  • 12. [The neuroleptic malignant syndrome].
    Dammers S, Zeit T, Leonhardt M, Schär V, Agelink MW.
    Dtsch Med Wochenschr; 1995 Dec 15; 120(50):1739-42. PubMed ID: 8542810
    [Abstract] [Full Text] [Related]

  • 13. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
    Tsai JH, Yang P, Yen JY, Chen CC, Yang MJ.
    Pharmacotherapy; 2005 Aug 15; 25(8):1156-9. PubMed ID: 16207109
    [Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
    Wait SD, Ponce FA, Killory BD, Wallace D, Rekate HL.
    J Neurosurg Pediatr; 2009 Sep 15; 4(3):217-21. PubMed ID: 19772404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS, Murungi JH.
    Ann Pharmacother; 2005 Jun 15; 39(6):1131-5. PubMed ID: 15840734
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB, Stark JE.
    Pharmacotherapy; 2006 Aug 15; 26(8):1180-2. PubMed ID: 16863495
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME, Yumru M, Savas HA, Cansel N, Herken H.
    World J Biol Psychiatry; 2007 Aug 15; 8(1):42-4. PubMed ID: 17366349
    [Abstract] [Full Text] [Related]

  • 20. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D, Burkhard J, Corti N, Schüpbach D, Fontanel D, Stäubli M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb 15; 41(2):125-7. PubMed ID: 16493563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.